Kuros Biosciences AG (LON:0RHR)

Market Cap	813.28M
Revenue (ttm)	66.60M
Net Income (ttm)	-3.78M
Shares Out	n/a
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,793
Average Volume	7,544
Open	23.87
Previous Close	24.35
Day's Range	23.50 - 24.00
52-Week Range	1.33 - 21.40
Beta	0.92
RSI	52.56
Earnings Date	Aug 13, 2025

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RHR

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial numbers in CHF